Does RIBOCICLIB Cause Pulmonary embolism? 263 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 263 reports of Pulmonary embolism have been filed in association with RIBOCICLIB (KISQALI). This represents 0.9% of all adverse event reports for RIBOCICLIB.
263
Reports of Pulmonary embolism with RIBOCICLIB
0.9%
of all RIBOCICLIB reports
50
Deaths
140
Hospitalizations
How Dangerous Is Pulmonary embolism From RIBOCICLIB?
Of the 263 reports, 50 (19.0%) resulted in death, 140 (53.2%) required hospitalization, and 35 (13.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for RIBOCICLIB.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which RIBOCICLIB Alternatives Have Lower Pulmonary embolism Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN